Table 2. X ± s, above/below the normal rang of SF, Hb, TRF in male primary lung cancer patients.
| Parameters | Serum ferritin | Hemoglobin | Transferrin | ||||||
|---|---|---|---|---|---|---|---|---|---|
| x ± s (ug/l) | above (n) | above(%) | x ± s (g/l) | below (n) | below(%) | x ±s (g/l) | below (n) | below(%) | |
| Smoking status | P=0.037 | P=0.003 | P=0.718 | ||||||
| Smoker | 378.7±159.1 | 354 | 85.5 | 130.9±18.2 | 108 | 26.1 | 2.2±0.6 | 226 | 54.6 |
| Never | 347.7±153.6 | 122 | 78.7 | 135.5±15.1 | 20 | 12.9 | 2.2±0.6 | 83 | 53.5 |
| Pathologic type* | P=0.486 | P=0.005 | P=0.417 | ||||||
| Adenocarcinoma | 365.8±165.3 | 247 | 82.1 | 134.7±17.0 | 57 | 18.9 | 2.3±0.6 | 156 | 51.8 |
| Squamous cell carcinoma | 374.9±148.0 | 147 | 86.0 | 128.9±18.6 | 48 | 28.1 | 2.2±0.5 | 94 | 55.0 |
| Adeno-squamous carcinoma | 319.9±157.4 | 13 | 72.2 | 125.4±19.0 | 7 | 38.9 | 2.2±0.4 | 11 | 61.1 |
| Small cell carcinoma | 394.0±148.4 | 48 | 90.6 | 131.4±15.7 | 10 | 18.9 | 2.3±0.6 | 29 | 54.7 |
| Not classifiable/Others | 376.8±157.8 | 21 | 80.8 | 130.8±14.1 | 6 | 23.1 | 2.1±0.5 | 19 | 73.1 |
| Stage* | P=0.055 | P=0.000 | P=0.154 | ||||||
| I | 334.3±167.1 | 72 | 75.0 | 137.7±13.8 | 9 | 9.4 | 2.3±0.5 | 41 | 42.7 |
| II | 393.3±164.6 | 39 | 84.8 | 136.3±13.8 | 8 | 17.4 | 2.3±0.7 | 24 | 52.2 |
| III | 366.2±158.6 | 162 | 83.5 | 128.3±19.2 | 61 | 31.4 | 2.2±0.5 | 110 | 56.7 |
| IV | 390.5±148.2 | 161 | 88.5 | 132.2±18.1 | 41 | 22.5 | 2.2±0.6 | 106 | 58.2 |
| Not classifiable | 359.9±159.1 | 42 | 82.4 | 132.7±14.8 | 9 | 17.6 | 2.2±0.5 | 28 | 54.9 |
| T* | P=0.000 | P=0.004 | P=0.005 | ||||||
| T1 | 313.5±167.7 | 54 | 71.1 | 138.1±13.5 | 8 | 10.5 | 2.4±0.6 | 36 | 47.4 |
| T2 | 358.6±163.7 | 181 | 81.2 | 132.3±17.0 | 50 | 22.4 | 2.3±0.6 | 114 | 51.1 |
| T3 | 421.7±135.3 | 115 | 93.5 | 128.2±19.7 | 41 | 33.3 | 2.1±0.5 | 80 | 65.0 |
| T4 | 383.7±143.5 | 77 | 88.5 | 131.9±19.3 | 18 | 20.7 | 2.3±0.6 | 44 | 50.6 |
| Tx (Not classifiable) | 360.2±160.1 | 49 | 81.7 | 132.5±14.5 | 11 | 18.3 | 2.2±0.5 | 35 | 58.3 |
| N* | P=0.133 | P=0.004 | P=0.049 | ||||||
| N0 | 351.2±164.7 | 105 | 80.2 | 136.5±14.7 | 15 | 11.5 | 2.3±0.5 | 64 | 48.9 |
| N1 | 378.0±154.0 | 47 | 87.0 | 134.7±16.1 | 11 | 20.4 | 2.3±0.7 | 28 | 51.9 |
| N2 | 365.1±151.5 | 170 | 83.7 | 130.3±18.5 | 50 | 24.6 | 2.3±0.5 | 104 | 51.2 |
| N3 | 401.0±160.5 | 105 | 86.8 | 129.1±19.6 | 41 | 33.9 | 2.1±0.5 | 78 | 64.5 |
| Nx (Not classifiable) | 360.2±160.1 | 49 | 81.7 | 132.5±14.5 | 11 | 18.3 | 2.2±0.5 | 35 | 58.3 |
| M* | P=0.140 | P=0.967 | P=0.752 | ||||||
| M0 | 361.5±162.7 | 274 | 81.3 | 132.1±17.6 | 78 | 23.1 | 2.2±0.5 | 175 | 51.9 |
| M1 | 389.5±148.0 | 160 | 88.4 | 132.2±18.1 | 41 | 22.7 | 2.2±0.6 | 106 | 58.6 |
| Mx (Not classifiable) | 359.9±159.1 | 42 | 82.4 | 132.7±14.8 | 9 | 17.6 | 2.2±0.5 | 28 | 54.9 |
* P>0.05. χ2 test in the composition of smoking patients and non-smoking patients.